RBX1 and cancer: Recently, ROC1 was reported to be overexpressed in a number of cancers [8–11], which was associated with poor prognosis of several cancers, such as non-muscle-invasive bladder transitional cell carcinoma (NMIBC) [9], gastric cancer [8, 10] and liver cancer [12].